Skip to main content
Top
Published in: Pediatric Nephrology 12/2016

01-12-2016 | Educational Review

Kidney retransplantation in children following rejection and recurrent disease

Authors: Rebecca C. Graves, Richard N. Fine

Published in: Pediatric Nephrology | Issue 12/2016

Login to get access

Abstract

Retransplantation accounts for approximately 15 % of the annual transplants performed in the USA, and in the recent International Collaborative Transplant Study report on pediatric patients 15.2 % of the 9209 patients included in the report were retransplant recipients. Although the significant advances in clinical management and newer immunosuppressive agents have had a significant impact on improving short-term allograft function, it is apparent that long-term allograft function remains suboptimal. Therefore, it is likely that the majority of pediatric renal allograft recipients will require one or more retransplants during their lifetime. Unfortunately, a second or subsequent graft in pediatric recipients has inferior long-term graft survival rates compared to initial grafts, with decreasing rates with each subsequent graft. Multiple issues influence the outcome of retransplantation, with the most significant being the cause of the prior transplant failure. Non-adherence-associated graft loss poses unresolved ethical issues that may impact access to retransplantation. Graft nephrectomy prior to retransplantation may benefit selected patients, but the impact of an in situ failed graft on the development of panel-reactive antibodies remains to be definitively determined. It is important that these and other factors discussed in this review be taken into consideration during the counseling of families on the optimal approach for their child who requires a retransplant.
Appendix
Available only for authorised users
Literature
1.
go back to reference Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD (2014) Risk factors for retransplant kidney recipients: relisting and outcomes from patients’ primary transplant. Am J Transplant 14(6):1356–1367CrossRefPubMed Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD (2014) Risk factors for retransplant kidney recipients: relisting and outcomes from patients’ primary transplant. Am J Transplant 14(6):1356–1367CrossRefPubMed
2.
go back to reference Opelz G, Döhler B (2010) Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 90(3):292–297CrossRefPubMed Opelz G, Döhler B (2010) Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 90(3):292–297CrossRefPubMed
3.
go back to reference Ploos van Amstel S, Vogelzang JL, Starink MV, Jager KJ, Groothoff JW (2015) Long-term risk of cancer in survivors of pediatric ESRD. Clin J Am Soc Nephrol 10(12):2198–2204CrossRefPubMed Ploos van Amstel S, Vogelzang JL, Starink MV, Jager KJ, Groothoff JW (2015) Long-term risk of cancer in survivors of pediatric ESRD. Clin J Am Soc Nephrol 10(12):2198–2204CrossRefPubMed
4.
go back to reference Van Arendonk KJ, Boyarsky BJ, Orandi BJ, James NT, Smith JM, Colombani PM, Segev DL (2014) National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics 133(4):594–601CrossRefPubMedPubMedCentral Van Arendonk KJ, Boyarsky BJ, Orandi BJ, James NT, Smith JM, Colombani PM, Segev DL (2014) National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics 133(4):594–601CrossRefPubMedPubMedCentral
5.
go back to reference Lofaro D, Jager KJ, Abu-Hanna A, Groothoff JW, Arikoski P, Hoecker B, Roussey-Kesler G, Spasojević B, Verrina E, Schaefer F, van Stralen KJ, ESPN/ERA-EDTA Registry (2015) Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. Nephrol Dial Transplant. doi:10.1093/ndt/gfv313 PubMed Lofaro D, Jager KJ, Abu-Hanna A, Groothoff JW, Arikoski P, Hoecker B, Roussey-Kesler G, Spasojević B, Verrina E, Schaefer F, van Stralen KJ, ESPN/ERA-EDTA Registry (2015) Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. Nephrol Dial Transplant. doi:10.​1093/​ndt/​gfv313 PubMed
6.
go back to reference Abraham EC, Wilson AC, Goebel J (2009) Current kidney allocation rules and their impact on a pediatric transplant center. Am J Transplant 9(2):404–408CrossRefPubMed Abraham EC, Wilson AC, Goebel J (2009) Current kidney allocation rules and their impact on a pediatric transplant center. Am J Transplant 9(2):404–408CrossRefPubMed
7.
go back to reference Van Arendonk KJ, Garonzik Wang JM, Deshpande NA, James NT, Smith JM, Montgomery RA, Colombani PM, Segev DL (2013) Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients. Transplantation 95(11):1360–1368CrossRefPubMedPubMedCentral Van Arendonk KJ, Garonzik Wang JM, Deshpande NA, James NT, Smith JM, Montgomery RA, Colombani PM, Segev DL (2013) Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients. Transplantation 95(11):1360–1368CrossRefPubMedPubMedCentral
9.
go back to reference Kousoulas L, Vondran FW, Syryca P, Klempnauer J, Schrem H, Lehner F (2015) Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants. J Transplant 2015:712049. doi: 10.1155/2015/712049 Kousoulas L, Vondran FW, Syryca P, Klempnauer J, Schrem H, Lehner F (2015) Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants. J Transplant 2015:712049. doi: 10.​1155/​2015/​712049
10.
go back to reference Harambat J, van Stralen KJ, Schaefer F, Grenda R, Jankauskiene A, Kostic M, Macher MA, Maxwell H, Puretic Z, Raes A, Rubik J, Sørensen SS, Toots U, Topaloglu R, Tönshoff B, Verrina E, Jager KJ (2013) Disparities in policies, practices and rates of pediatric kidney transplantation in Europe. Am J Transplant 13(8):2066–2074CrossRefPubMed Harambat J, van Stralen KJ, Schaefer F, Grenda R, Jankauskiene A, Kostic M, Macher MA, Maxwell H, Puretic Z, Raes A, Rubik J, Sørensen SS, Toots U, Topaloglu R, Tönshoff B, Verrina E, Jager KJ (2013) Disparities in policies, practices and rates of pediatric kidney transplantation in Europe. Am J Transplant 13(8):2066–2074CrossRefPubMed
11.
go back to reference Dobbels F, Hames A, Aujoulat I, Heaton N, Samyn M (2012) Should we retransplant a patient who is non-adherent? A literature review and critical reflection. Pediatr Transplant 16(1):4–11CrossRefPubMed Dobbels F, Hames A, Aujoulat I, Heaton N, Samyn M (2012) Should we retransplant a patient who is non-adherent? A literature review and critical reflection. Pediatr Transplant 16(1):4–11CrossRefPubMed
12.
go back to reference Gralla J, Tong S, Wiseman AC (2013) The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients. Transplantation 95(10):1218–1224CrossRefPubMed Gralla J, Tong S, Wiseman AC (2013) The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients. Transplantation 95(10):1218–1224CrossRefPubMed
13.
go back to reference Minson S, Muñoz M, Vergara I, Mraz M, Vaughan R, Rees L, Olsburgh J, Calder F, Shroff R (2013) Nephrectomy for the failed renal allograft in children: predictors and outcomes. Pediatr Nephrol 28(8):1299–1305CrossRefPubMed Minson S, Muñoz M, Vergara I, Mraz M, Vaughan R, Rees L, Olsburgh J, Calder F, Shroff R (2013) Nephrectomy for the failed renal allograft in children: predictors and outcomes. Pediatr Nephrol 28(8):1299–1305CrossRefPubMed
14.
go back to reference Ahmad N, Ahmed K, Mamode N (2009) Does nephrectomy of failed allograft influence graft survival after re-transplantation? Nephrol Dial Transplant 24(2):639–642CrossRefPubMed Ahmad N, Ahmed K, Mamode N (2009) Does nephrectomy of failed allograft influence graft survival after re-transplantation? Nephrol Dial Transplant 24(2):639–642CrossRefPubMed
15.
go back to reference Dinis P, Nunes P, Marconi L, Furriel F, Parada B, Moreira P, Figueiredo A, Bastos C, Roseiro A, Dias V, Rolo F, Macário F, Mota A (2014) Kidney retransplantation: removal or persistence of the previous failed allograft? Transplant Proc 46(6):1730–1734CrossRefPubMed Dinis P, Nunes P, Marconi L, Furriel F, Parada B, Moreira P, Figueiredo A, Bastos C, Roseiro A, Dias V, Rolo F, Macário F, Mota A (2014) Kidney retransplantation: removal or persistence of the previous failed allograft? Transplant Proc 46(6):1730–1734CrossRefPubMed
16.
go back to reference Schleicher C, Wolters H, Kebschull L, Anthoni C, Suwelack B, Senninger N, Palmes D, Mersfeld B (2011) Impact of failed allograft nephrectomy on initial function and graft survival after kidney retransplantation. Transpl Int 24(3):284–291CrossRefPubMed Schleicher C, Wolters H, Kebschull L, Anthoni C, Suwelack B, Senninger N, Palmes D, Mersfeld B (2011) Impact of failed allograft nephrectomy on initial function and graft survival after kidney retransplantation. Transpl Int 24(3):284–291CrossRefPubMed
17.
go back to reference Fadli SE, Pernin V, Nogue E, Macioce V, Picot MC, Ramounau-Pigot A, Garrigue V, Iborra F, Mourad G, Thuret R (2014) Impact of graft nephrectomy on outcomes of second kidney transplantation. Int J Urol 21(8):797–802CrossRefPubMed Fadli SE, Pernin V, Nogue E, Macioce V, Picot MC, Ramounau-Pigot A, Garrigue V, Iborra F, Mourad G, Thuret R (2014) Impact of graft nephrectomy on outcomes of second kidney transplantation. Int J Urol 21(8):797–802CrossRefPubMed
18.
go back to reference Hirsch HH, Randhawa P (2013) AST infectious diseases community of practice. BK polyomavirus in solid organ transplantation. Am J Transplant Suppl 4:179–188CrossRef Hirsch HH, Randhawa P (2013) AST infectious diseases community of practice. BK polyomavirus in solid organ transplantation. Am J Transplant Suppl 4:179–188CrossRef
19.
go back to reference Lucarelli G, Vavallo A, Bettocchi C, Losappio V, Gesualdo L, Grandaliano G, Selvaggi FP, Battaglia M, Ditonno P (2013) Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. World J Urol 31(4):959–963CrossRefPubMed Lucarelli G, Vavallo A, Bettocchi C, Losappio V, Gesualdo L, Grandaliano G, Selvaggi FP, Battaglia M, Ditonno P (2013) Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. World J Urol 31(4):959–963CrossRefPubMed
20.
go back to reference Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC (2010) Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am J Transplant 10(5):1312–1315CrossRefPubMed Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC (2010) Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am J Transplant 10(5):1312–1315CrossRefPubMed
22.
go back to reference Johnson SR, Cherikh WS, Kauffman HM, Pavlakis M, Hanto DW (2006) Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. Am J Transplant 6(11):2743–2749 Johnson SR, Cherikh WS, Kauffman HM, Pavlakis M, Hanto DW (2006) Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. Am J Transplant 6(11):2743–2749
24.
go back to reference Dunn TB, Browne BJ, Gillingham KJ, Kandaswamy R, Humar A, Payne WD, Sutherland DE, Matas AJ (2009) Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant 9(6):1337–1346CrossRefPubMedPubMedCentral Dunn TB, Browne BJ, Gillingham KJ, Kandaswamy R, Humar A, Payne WD, Sutherland DE, Matas AJ (2009) Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant 9(6):1337–1346CrossRefPubMedPubMedCentral
25.
go back to reference Cochat P, Fargue S, Mestrallet G, Jungraithmayr T, Koch-Nogueira P, Ranchin B, Zimmerhackl LB (2009) Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 24(11):2097–2108CrossRefPubMedPubMedCentral Cochat P, Fargue S, Mestrallet G, Jungraithmayr T, Koch-Nogueira P, Ranchin B, Zimmerhackl LB (2009) Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 24(11):2097–2108CrossRefPubMedPubMedCentral
26.
go back to reference Sprangers B, Kuypers DR (2013) Recurrence of glomerulonephritis after renal transplantation. Transplant Rev 27(4):126–134CrossRef Sprangers B, Kuypers DR (2013) Recurrence of glomerulonephritis after renal transplantation. Transplant Rev 27(4):126–134CrossRef
27.
go back to reference Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334(14):878–883CrossRefPubMed Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334(14):878–883CrossRefPubMed
28.
go back to reference Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952–960CrossRefPubMedPubMedCentral Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952–960CrossRefPubMedPubMedCentral
29.
go back to reference Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A (2014) Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 85(3):649–658CrossRefPubMed Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A (2014) Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 85(3):649–658CrossRefPubMed
30.
go back to reference Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, Morozumi K (2014) Early recurrence of active IgA nephropathy after kidney transplantation. Nephrol Suppl 3:45–48CrossRef Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, Morozumi K (2014) Early recurrence of active IgA nephropathy after kidney transplantation. Nephrol Suppl 3:45–48CrossRef
31.
go back to reference Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 23(9):1579–1587CrossRefPubMedPubMedCentral Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 23(9):1579–1587CrossRefPubMedPubMedCentral
32.
go back to reference Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M (2013) Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant 13(8):2201–2206CrossRefPubMed Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M (2013) Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant 13(8):2201–2206CrossRefPubMed
33.
go back to reference Tran H, Chaudhuri A (2014) Concepcion W, Grimm PC. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Pediatr Nephrol 29(3):477–480CrossRefPubMed Tran H, Chaudhuri A (2014) Concepcion W, Grimm PC. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Pediatr Nephrol 29(3):477–480CrossRefPubMed
34.
go back to reference Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, Tamariz L, Carvalho C, Kupin W, Ladino M, LeClercq B, Jaraba I, Carvalho D, Carles E, Roth D (2010) Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol 21(7):1200–1207CrossRefPubMedPubMedCentral Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, Tamariz L, Carvalho C, Kupin W, Ladino M, LeClercq B, Jaraba I, Carvalho D, Carles E, Roth D (2010) Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol 21(7):1200–1207CrossRefPubMedPubMedCentral
35.
go back to reference Silvariño R, Noboa O, Cervera R (2014) Anti-glomerular basement membrane antibodies. Isr Med Assoc J 16(11):727–732PubMed Silvariño R, Noboa O, Cervera R (2014) Anti-glomerular basement membrane antibodies. Isr Med Assoc J 16(11):727–732PubMed
36.
go back to reference Kattah A, Ayalon R, Beck LH Jr, Sethi S, Sandor DG, Cosio FG, Gandhi MJ, Lorenz EC, Salant DJ, Fervenza FC (2015) Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy. Am J Transplant 15(5):1349–1359CrossRefPubMedPubMedCentral Kattah A, Ayalon R, Beck LH Jr, Sethi S, Sandor DG, Cosio FG, Gandhi MJ, Lorenz EC, Salant DJ, Fervenza FC (2015) Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy. Am J Transplant 15(5):1349–1359CrossRefPubMedPubMedCentral
37.
go back to reference Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10(6):651–657 Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10(6):651–657
38.
go back to reference Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation 73(3):394–403CrossRefPubMed Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation 73(3):394–403CrossRefPubMed
39.
go back to reference Browne G, Brown PA, Tomson CR, Fleming S, Allen A, Herriot R, Pusey CD, Rees AJ, Turner AN (2004) Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int 65(2):675–681CrossRefPubMed Browne G, Brown PA, Tomson CR, Fleming S, Allen A, Herriot R, Pusey CD, Rees AJ, Turner AN (2004) Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int 65(2):675–681CrossRefPubMed
40.
go back to reference Holmberg C, Jalanko H (2014) Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol 29(12):2309–2317CrossRefPubMedPubMedCentral Holmberg C, Jalanko H (2014) Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol 29(12):2309–2317CrossRefPubMedPubMedCentral
41.
go back to reference Mohan S, Palanisamy A, Tsapepas D, Tanriover B, Crew RJ, Dube G, Ratner LE, Cohen DJ, Radhakrishnan J (2012) Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 23(12):2061–2071CrossRefPubMedPubMedCentral Mohan S, Palanisamy A, Tsapepas D, Tanriover B, Crew RJ, Dube G, Ratner LE, Cohen DJ, Radhakrishnan J (2012) Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 23(12):2061–2071CrossRefPubMedPubMedCentral
42.
go back to reference Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC (2014) Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients. Transplantation 98(3):312–319CrossRefPubMed Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC (2014) Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients. Transplantation 98(3):312–319CrossRefPubMed
43.
go back to reference Yabu JM, Pando MJ, Busque S, Melcher ML (2013) Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases. Transplant Proc 45(1):82–87CrossRefPubMedPubMedCentral Yabu JM, Pando MJ, Busque S, Melcher ML (2013) Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases. Transplant Proc 45(1):82–87CrossRefPubMedPubMedCentral
44.
go back to reference Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, Aouizerate J, Matignon M, Rostaing L, Lang P, Grimbert P (2012) Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 25(5):e62–e66CrossRefPubMed Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, Aouizerate J, Matignon M, Rostaing L, Lang P, Grimbert P (2012) Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 25(5):e62–e66CrossRefPubMed
45.
go back to reference Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M (2011) Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation. Pediatr Transplant 15(5):495–501CrossRefPubMed Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M (2011) Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation. Pediatr Transplant 15(5):495–501CrossRefPubMed
46.
go back to reference McCaughan JA, O’Rourke DM, Courtney AE (2012) Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am J Transplant 12(4):1046–1051CrossRefPubMed McCaughan JA, O’Rourke DM, Courtney AE (2012) Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am J Transplant 12(4):1046–1051CrossRefPubMed
47.
go back to reference Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V, French Study Group for aHUS/C3G (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8(11):643–657CrossRefPubMed Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V, French Study Group for aHUS/C3G (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8(11):643–657CrossRefPubMed
48.
go back to reference Oosterveld MJ, Garrelfs MR, Hoppe B, Florquin S, Roelofs JJ, van den Heuvel LP, Amann K, Davin JC, Bouts AH, Schriemer PJ, Groothoff JW (2015) Eculizumab in pediatric dense deposit disease. Clin J Am Soc Nephrol 10(10):1773–1782CrossRefPubMedPubMedCentral Oosterveld MJ, Garrelfs MR, Hoppe B, Florquin S, Roelofs JJ, van den Heuvel LP, Amann K, Davin JC, Bouts AH, Schriemer PJ, Groothoff JW (2015) Eculizumab in pediatric dense deposit disease. Clin J Am Soc Nephrol 10(10):1773–1782CrossRefPubMedPubMedCentral
49.
go back to reference Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F (2014) Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 371(4):303–312CrossRefPubMed Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F (2014) Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 371(4):303–312CrossRefPubMed
50.
go back to reference Van Arendonk KJ, James NT, Orandi BJ, Garonzik-Wang JM, Smith JM, Colombani PM, Segev DL (2013) Order of donor type in pediatric kidney transplant recipients requiring retransplantation. Transplantation 96(5):487–493CrossRefPubMedPubMedCentral Van Arendonk KJ, James NT, Orandi BJ, Garonzik-Wang JM, Smith JM, Colombani PM, Segev DL (2013) Order of donor type in pediatric kidney transplant recipients requiring retransplantation. Transplantation 96(5):487–493CrossRefPubMedPubMedCentral
Metadata
Title
Kidney retransplantation in children following rejection and recurrent disease
Authors
Rebecca C. Graves
Richard N. Fine
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 12/2016
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-016-3346-0

Other articles of this Issue 12/2016

Pediatric Nephrology 12/2016 Go to the issue